Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer

Published:2019-10-15 Issue:1 Volume:80 Page:65-73
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Shao Longjiang¹,Kahraman Nermin²,Yan Ge¹,Wang Jianghua¹,Ozpolat Bulent²,Ittmann Michael¹^ORCID

Affiliation:

1. Department of Pathology and Immunology, Baylor College of MedicineMichael E. DeBakey Department of Veterans Affairs Medical Center Houston Texas

2. Department of Experimental TherapeuticsThe University of Texas MD Anderson Cancer Center Houston Texas

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23918

Reference42 articles.

1. Cancer statistics, 2018

2. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

3. Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer

4. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

5. Confirmation of the high frequency of theTMPRSS2/ERG fusion gene in prostate cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer;Journal of Ethnopharmacology;2024-09

2. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06

3. Nanomedicine for Prostate Cancer Treatment;BioNanoScience;2024-05-28

4. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

5. Nanotherapeutics for prostate cancer treatment: A comprehensive review;Biomaterials;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3